Ronesans Gayrimenkul Yatirim AS
IST:RGYAS.E
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
97.65
167.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
RGYAS.E Price Targets Summary
Ronesans Gayrimenkul Yatirim AS
According to Wall Street analysts, the average 1-year price target for RGYAS.E is 221.1 TRY with a low forecast of 188.15 TRY and a high forecast of 245.7 TRY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Ronesans Gayrimenkul Yatirim AS
For the last 1 year the compound annual growth rate for Ronesans Gayrimenkul Yatirim AS's operating income is 16%. The projected CAGR for the next 3 years is 14%.
Net Income
Forecast
Net Income Estimate
Ronesans Gayrimenkul Yatirim AS
For the last 1 year the compound annual growth rate for Ronesans Gayrimenkul Yatirim AS's net income is -82%. The projected CAGR for the next 3 years is 35%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RGYAS.E's stock price target?
Price Target
221.1
TRY
According to Wall Street analysts, the average 1-year price target for RGYAS.E is 221.1 TRY with a low forecast of 188.15 TRY and a high forecast of 245.7 TRY.
What is Ronesans Gayrimenkul Yatirim AS's Revenue forecast?
Projected CAGR
17%
For the last 1 year the compound annual growth rate for Ronesans Gayrimenkul Yatirim AS's revenue is 14%. The projected CAGR for the next 4 years is 17%.
What is Ronesans Gayrimenkul Yatirim AS's Operating Income forecast?
Projected CAGR
14%
For the last 1 year the compound annual growth rate for Ronesans Gayrimenkul Yatirim AS's operating income is 16%. The projected CAGR for the next 3 years is 14%.
What is Ronesans Gayrimenkul Yatirim AS's Net Income forecast?
Projected CAGR
35%
For the last 1 year the compound annual growth rate for Ronesans Gayrimenkul Yatirim AS's net income is -82%. The projected CAGR for the next 3 years is 35%.